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Murine monoclonal IgG t antibodies (MAb), designated Aq-ll and Aq-12, were prepared against the photoprotein 
aequorin from jelly fish. Aequorin is a calcium-sensitive photoprotein which consists of a single polypeptide chain, apo- 
aequorin, and a functional chromophore, coelenterazine. Native aequorin consists of two species with molecular masses 
of 25 and 23.5 kDa. MAb Aq-12 was found by immunoblot analysis to bind specifically to the 25 kDa species, while 
MAb Aq-11 reacted with the 23.5 kDa protein. Activation of apoaequorin with coelenterazine was associated with a 
shift of the 23.5 kDa molecule to the 25 kDa species. In contrast, treatment with calcium ions induced a shift back to 
the 23.5 kDa form. These changes between the active and inactive forms were identified by reactivity with MAbs Aq-I 1 
and Aq-12. The results thus indicate that these MAbs should be useful in monitoring activation of this photoprotein. 
Aequorin; Monoclonal antibody; Active form; Inactive form 
1. INTRODUCTION 
Aequorin is a bioluminescent protein from the 
jelly fish which emits blue light in the presence of 
calcium ions [1,2]. Aequorin has thus been used as 
a calcium indicator [3,4]. Aequorin is dissociated 
into apoaequorin and the oxidized chromophore, 
coelenteramide. Dissociated apoaequorin can be 
reconstituted by incubation with coelenterazine in 
2-mercaptoethanol (2ME), EDTA and 30 mM 
Tris-HCl buffer (pH 7.6) for 2 h at 4°C [5]. Activa- 
tion of aequorin with coelenterazine is associated 
with a shift in apparent molecular mass from 23.5 
to 25 kDa. In contrast, calcium treatment induces 
conversion of the activated 25 kDa form back to 
the inactivated 23.5 kDa species [6,7] (fig.l). A 
cDNA for apoaequorin has recently been cloned 
and sequenced [8-11]. However, the structure and 
function of the aequorin emission site remain 
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unclear. Moreover, previous tudies have not iden- 
tified monoclonal antibodies against aequorin, 
particularly against epitopes involved in the func- 
tion of this photoprotein. In this presentation, we 
demonstrate he production of MAbs against he 
active and inactive configurations of aequorin. 
2. MATERIALS AND METHODS 
2.1. Animals and chemicals 
New Zealand Black-White FI female mice aged 5 weeks were 
used for immunization (CLEA-Japan, Inc. Tokyo). Highly 
purified natural aequorin was obtained from Dr J.R. Blinks 
(Mayo Foundation, Rochester, MN) [12], and coelenterazine, 
2-(p-bydroxybenzyl)-6-(p-hydroxyphenyl)-3,7-dihydroimidazo- 
(l,2-alpyrazin-3-one), was synthesized by previously described 
techniques [131. 
2.2. Preparation of monoclonal ntibodies 
The mice were immunized with purified aequorin. Spleen cells 
from immunized mice were fused with mouse myeloma cells, 
NSI/1.Ag4.1 [14]. Myeloma cells were cultured in RPMI 1640 
medium (Gibco, Grand Island, NY) supplemented with 15070 
horse serum (Pel-Freeze Nippon Bio-supply, Tokyo), 2 mM L- 
glutamine (WAKO pure chemicals, Tokyo), 1 mM sodium 
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Fig.1. A model of the active and inactive configurations of an aequorin molecule. 
pyruvate (Sigma) and 10 mM Hepes (Sigma). Polyethylene 
glycol (50070; 1540 Da from BDH chemicals Poole, England) 
was used for the fusion. 
The fused cells were distributed into 96-well tissue culture 
plates (Costar, Cambridge, MA). HAT (100/~1; 0.1 mM hypo- 
xanthine, 0.016 mM thymidine and 0.4 lzM aminopterin) selec- 
tion was started 24 h later. On days 2, 3, 5, 8, 11 and 14, 100/zl 
medium was removed from each well prior to adding 100/~1 
fresh HAT selection medium. Hybridoma growth was detect- 
able by day 5 and colonies by day 10. 
2.3. Screening of monoclonal antibodies 
The hybridomas were screened by an enzyme linked immuno- 
sorbent assay (ELISA) [15]. Micro-test II1 flexible assay plates 
(Becton Dickinson, Oxnard, CA) were coated with aequorin in 
a 0.05 M bicarbonate-carbonate buffer (pH 9.5) by incubation 
overnight at 4°C. The plates were washed 7 times with 0.01 M 
PBS (pH 7.6) containing 0.05070 Tween-20 (PBS-Tween) and 
blocked with 20070 horse serum in PBS. Each well was washed 3
times with PBS-Tween and incubated overnight at 4°C with 
hybridoma supernatant diluted 1:5 in PBS. The plates were 
washed, reacted with 0.5/zg per ml peroxidase labeled anti- 
mouse IgG for 2 h at room temperature and then washed again 
7 times. Enzyme substrate, 0.5 mg per ml of o-phenylenedi- 
amine (Sigma) in Mcllvain's buffer, pH 5.5, containing 0.005 % 
peroxide, was added to the wells and reacted for 30 min at room 
temperature. The reactions were stopped by adding 0.4 M 
sulfuric acid and the wells were then monitored for absorbance 
at 492 nm on a Microreader (Corona, Ibaragi, Japan). 
2.4. Immunoblot analysis 
ELISA positive wells were further selected by immunoblot 
analysis. Aequorin was electrophoresed in a preparative 
SDS/12% polyacrylamide slab gel [16] and transferred electro- 
pboretically to nitrocellulose sheets with a Atto transfer ap- 
paratus at 70 V for 2 h [17]. The nitrocellulose sheets were 
blocked with 200/0 horse serum in 0.05 M Tris-HC1 buffer (TBS) 
for 1 h, and then incubated with hybridoma supernatants over- 
night at 4°C. After washing 3 times in TBS on a shaker, the 
sheets were incubated with peroxidase labeled anti-mouse IgG 
for 90 min at room temperature and then washed again. 
Specifically bound antibodies were visualized by incubation 
with 4-chloro-1-naphthol (Bio-Rad, CA) in methanol with McI1- 
vain's buffer (pH 5.5) and 0.01070 peroxide. 
2.5. Purification of monoclonal antibody 
Antibody was purified from mouse ascites [16]. Ascites was 
produced by pristane (tetramethylpentadecane, Aldrich, 
Milwaukee, Wl)-primed mice in which 1 × l07 hybridoma cells 
were injected intraperitoneally. The lgG fraction of the ascites 
was purified by precipitation with 3307o ammonium sulfate 
followed by Sephacryl S-300 chromatography. 
2.6. Regeneration faequorin activity 
Regeneration f aequorin activity was carried out by incuba- 
tion with coelenterazine i  30 mM TBS (pH 7.6), 0.01 M EDTA 
and 2ME for 2 h at 4°C. Luminescence activity of regenerated 
aequorin was determined asdescribed by Blinks et al. [12]. 
3. RESULTS 
The hybridomas were screened by ELISA for re- 
activity with aequorin. Forty of 792 clones were 
selected and studied further by Western blot 
analysis. Two hybridomas, designated Aq-11 and 
Aq-12, produced high-affinity IgG1 antibodies that 
reacted with purified aequorin. The reactivity of 
these MAbs with native a quorin is shown in fig.2. 
The binding of MAb Aq-I 1 (5/~g/ml) was pprox. 
10-fold greater than that of MAb Aq-12 (8/~g/ml) 
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Fig.2. Reactivity to natural aequorin of Aq-ll and Aq-12 by 
EL1SA. The reactivity of MAbs Aq-ll (~)  and Aq-12 
(--0--) to serial 2-fold dilutions of native aequorin. 
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against he same aequorin preparation (fig.2). Fur- 
thermore, MAb Aq-11 was found to react with re- 
combinant apoaequorin, while there was no detect- 
able reactivity of MAb Aq-12 with this protein 
(fig.3). These findings indicated that MAbs Aq-11 
and Aq-12 recognize distinct epitopes on the ae- 
quorin molecule. The electrophoretic mobility of 
aequorin in a SDS-polyacrylamide g l is shown in 
fig.4A. Coomassie blue staining revealed two 
species with apparent molecular masses of 25 and 
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Fig.3. Reactivity of MAbs Aq-I 1 and Aq-12 with recombinant 
apoaequorin by ELISA. The reactivity of MAbs Aq-11 (~)  
and Aq-12 ( = ) to serial 2-fold dilutions of recombinant apo- 
aequorin was determined by ELISA. 
Fig.4. Reactivity of MAbs Aq-ll and Aq-12 with natural ae- 
quorin. Natural aequorin was subjected to electrophoresis in a 
SDS/12% polyacrylamide gel, transferred to nitrocellulose 
paper and reacted with MAb Aq-ll (lane B) or MAb Aq-12 
(lane C). Molecular mass markers (lane A) and natural aequorin 
(lane A) were stained with Coomassie blue after transfer. 
23.5 kDa. Of interest, MAb Aq- l l  reacted only 
with the 23.5 kDa species (fig.4B). In contrast, 
MAb Aq-12 had specific reactivity with the 25 kDa 
aequorin molecule. The presence of relatively 
greater amounts of the 23.5 kDa species was in 
agreement with the demonstration i  fig.5 that 
MAb Aq-11 was more reactive than MAb Aq-12 
with this aequorin preparation. The electrophoretic 
mobility of native aequorin and calcium- 
inactivated aequorin is shown in fig.5A. Calcium 
treatment was associated with an increase in elec- 
trophoretic mobility of the apparent 25 kDa 
species (fig.5A). Furthermore, binding of MAb 
Aq- l l  with the active and inactive forms of ae- 
quorin demonstrated the presence of the 23.5 kDa 
species in both preparations (fig.5B). In contrast, 
binding of MAb Aq-12 to the 25 kDa protein was 
detectable with the active, but not the calcium- 
inactivated aequorin (fig.5C). These findings sug- 
gested that MAb Aq-12 reacts specifically with the 
active 25 kDa species, while MAb Aq- l l  detects 
only the inactive 23.5 kDa form. Indeed, there was 
increased reactivity with MAb Aq-12 and de- 
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demonstrate he selectivity of these MAbs for the 
active and inactive conformations of aequorin. 
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Fig.5. Reactivity of MAbs Aq-11 and Aq-12 with the active and 
inactive forms of aequorin. Natural aequorin (lanes A2, B4, C6, 
D2, E4, F6), calcium-inactivated aequorin (A3, B5, C7) and 
coelenterazine-activated equorin (D3, E5, F7) were subjected 
to electrophoresis in a SDS/12% polyacrylamide gel, transfer- 
red to nitrocellulose paper and stained with Coomassie blue (A 
and D), reacted with MAb Aq-11 (B and E) or reacted with MAb 
Aq-12 (C and F). Lanes A1 and D1 represent molecular mass 
markers tained with Coomassie blue. 
creased binding of MAb Aq- I 1 when the aequorin 
preparation was activated with coelenterazine 
(fig.5D-F). Taken together, these results 
4. DISCUSSION 
Electrophoresis of native aequorin revealed two 
species with apparent molecular masses at 25 and 
23.5 kDa. MAb Aq-12 was found to react with the 
25 kDa molecule, while MAb Aq-11 was specifical- 
ly reactive with the 23.5 kDa protein. Calcium in- 
duced a shift in electrophoretic mobility of the 
25 kDa species to the 23.5 kDa form. In contrast, 
regeneration with coelenterazine shifted the 
23.5 kDa inactive form to the active 25 kDa con- 
formation. Purified recombinant apoaequorin was 
prepared from E. coli expressing a plasmid, the 
apoaequorin cDNA (Inouye, in preparation). The 
electrophoretic mobility of apoaequorin revealed 
an apparent molecular mass at approx. 23.5 kDa. 
MAb Aq-11 reacted with the recombinant apoae- 
quorin and the 23.5 kDa species of native ae- 
quorin. In contrast, MAb Aq-12 had no detectable 
reactivity with apoaequorin. Furthermore, while 
MAb Aq-ll reacted with the inactive form of ae- 
quorin, MAb Aq-12 had no detectable reactivity 
after calcium inactivation of native aequorin. 
These findings suggest that the apparent molecular 
mass of aequorin shifts with a change in configura- 
tion between the active and inactive forms. Fur- 
thermore, the results suggest that the 25 kDa 
species of aequorin represents the active form, 
while the 23.5 kDa species is the inactive form. 
Finally, the present findings represent the first 
demonstration f the identification of activated in- 
active configuration of a protein by specific mono- 
clonal antibodies. 
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